Enhabit Acquisition Clears Antitrust Hurdle with Early HSR Termination
EHAB has more than doubled off its 52-week low of $6.47.
Summary
Enhabit, Inc. has received early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, a critical step in its previously announced $1.1 billion acquisition by Kinderhook. This development removes a significant regulatory hurdle, de-risking the transaction and paving the way for its timely completion. The news follows the company's recent definitive proxy filing for a special meeting on May 12, 2026, where shareholders will vote on the proposed acquisition. Traders should now focus on the upcoming shareholder vote as the next major catalyst for the deal's closing.
At the time of this announcement, EHAB was trading at $13.73 on NYSE in the Life Sciences sector, with a market capitalization of approximately $696.4M. The 52-week trading range was $6.47 to $14.22. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.